Commercial Credit Report for Timing Pharmaceutical Co Ltd

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Timing Pharmaceutical Co Ltd is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Timing Pharmaceutical Co Ltd

Phone: +886 285218883p:+886 285218883	NEW TAIPEI, 242 Taiwan	Ticker: 66596659

Business Summary

Timing Pharmaceutical Co Ltd is a Taiwan-based company mainly engaged in the manufacturing of traditional Chinese medicine and pharmaceuticals. Its main products include concentrated Chinese medicine preparations, health foods, and traditional Chinese medicine formulations. The Company accepts applications for licenses and permits for Chinese medicine, food, and finished pharmaceutical products, and undertakes contract manufacturing. It continuously invests in research and development for new pilot projects each year. Through a comprehensive sales network, it has established a full-fledged professional supply chain and service network covering Chinese medicine hospitals and major pharmacies throughout Taiwan. In addition, The Company also provides testing services and contract research and development and manufacturing organization (CDMO) services. The Company operates products in domestic and overseas markets.

(Source: PROSPECTUS)

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
6/30/2025	12/31/2024	-	-	-	-	-

Industries

SIC Code	Description
2834	Pharmaceutical preparations
2833	Medicinal chemicals and botanical products
2099	Food preparations, not elsewhere classified
2836	Biological products, except diagnostic substances
2835	In vitro and in vivo diagnostic substances

Officers and Directors

Title	Name	Title Date	Start Date
Chairman of the Board	YongningZhan	3/31/2022	10/15/2019
General Manager	BolunWang	3/31/2022	3/31/2022
Director	AnminGao	10/15/2019	10/15/2019
4 additional Officers and Directors records available in full report.

General Information

Number of Employees:	490	(As of 6/30/2025)
Outstanding Shares:	85,883,009	(As of 6/30/2025)
Stock Exchange:	TPO
Fax Number:	+886 285218977

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN